MARKET PULSE-Alnylam, Beam, NII Holdings, Rosetta Genomics, BlackBerry
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock indexes were little changed on Monday. The Dow Jones industrial average was unchanged at 16,437.5, the S&P 500 was down 0.01 percent at 1,842.18 and the Nasdaq Composite was up 0.04 percent at 4176.15.
** ALNYLAM PHARMACEUTICALS INC, $107.66, +62.60 pct
French drugmaker Sanofi will buy a 12 percent stake in Alnylam Pharmaceuticals for $700 million and deepen their partnership to develop drugs for rare genetic diseases.
** BEAM INC, $83.1, +24.09 pct
Suntory Holdings Ltd said it plans to buy Beam for $16 billion, including debt, making the Japanese company the world's third-largest maker of distilled drinks. Beam's brands include Jim Beam, Maker's Mark, Sauza, Canadian Club and Courvoisier.
** SODASTREAM INTERNATIONAL LTD, $38.98, -21.87 pct
The Israeli company, which manufactures soda makers, estimated full-year revenue below analyst's expectations, hurt by a challenging holiday season selling in the United States. The company said it expected 2013 revenue of about $562.0 million, compared with analysts' estimates of $563.8 million. Continued...